Mar 4 |
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
|
Feb 28 |
Cassava Sciences Inc (SAVA) Reports Full-Year 2023 Financial Results
|
Feb 28 |
Cassava Sciences GAAP EPS of -$0.50
|
Feb 28 |
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
|
Feb 21 |
Exit Now! 3 Biotech Stocks to Sell in February 2024
|
Feb 10 |
Cassava Sciences And Alzheimer's Disease: Opaque Clarity
|
Feb 7 |
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
|
Feb 5 |
Cassava Sciences, Inc. (NASDAQ:SAVA) most popular amongst retail investors who own 59% of the shares, institutions hold 31%
|
Feb 3 |
Is There Any Hope for Cassava Sciences Stock?
|
Jan 29 |
(SAVA) - Analyzing Cassava Sciences's Short Interest
|